Navigation Links
Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk
Date:1/31/2009

CINCINNATI, Jan. 31 /PRNewswire-FirstCall/ -- The Kroger Co. (NYSE: KR) said today it is recalling peanut butter store-baked and store-packaged cookies and select cakes sold in its family of stores because the products have the potential to be contaminated with Salmonella.

Stores under the following names in the 31 states where Kroger operates are included in this recall: Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, King Soopers, Smith's, Dillons, QFC, City Market, Foods Co., Jay C, Scott's, Owen's, Baker's, Gerbes, Hilander and Pay Less.

No illnesses have been reported in connection with the cookies and cakes.

Item Descriptions:

Kroger is recalling all packages of the following Kroger, Store-Brand and Private Selection store-baked and store-packaged cookies:

  • Peanut Butter Cookies - Regular, Jumbo, Decorated, Iced, Gourmet, Mini and Sandwich cookies
  • Assorted and Variety Bakery Cookies - Regular and Jumbo
  • Private Selection Peanut Chocolate Chunk Cookies
  • Private Selection Gourmet Variety Cookie Trays

Kroger is recalling all sizes of the following Private Selection Cakes, including whole, half and packaged slices:

  • Private Selection Chocolate Trio Single-Layer and Double-Layer Iced Cakes

Customers who have purchased any of the cookies or cakes listed above should not consume these products and should return them to a store for a full refund or replacement.

The products Kroger is recalling may be associated with the peanut product recall by Peanut Corporation of America (PCA). The FDA has indicated that PCA is the focus of its investigation into Salmonella-related illnesses that may be linked to contaminated peanut products. For more information, please visit the FDA's website at www.fda.gov.

Kroger continues to follow FDA guidelines and, for the safety of customers, has withdrawn other products from sale that contain peanut ingredients implicated in this outbreak, as directed by the FDA and suppliers involved.

Salmonella is an organism that can cause serious and sometimes fatal infections, particularly in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain. For more information on Salmonella, please visit the Centers for Disease Control and Prevention's website at www.cdc.gov.

According to the FDA, peanut butter sold in jars, including Kroger brand peanut butter sold in the retailer's family of stores, is not involved in the ongoing investigation.

Customers who have questions about the cookie and cake recall may contact Kroger toll-free at (800) 632-6900. For more information, please visit Kroger's website at www.kroger.com/recalls.

Kroger is notifying customers about this recall by placing signs in stores in bakery departments. Kroger is also activating its register receipt and phone call notification systems to alert customers about recalls of products they may have purchased.

Kroger, one of the nation's largest retail grocery chains, employs more than 320,000 associates who serve customers in 2,477 supermarkets and multi-department stores in 31 states. Kroger operates stores under two dozen local banner names including Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, King Soopers, Smith's, Dillons, QFC and City Market. In addition, Kroger associates serve customers in 778 convenience stores, 392 fine jewelry stores and 750 supermarket fuel centers the Company operates. Kroger also operates 41 food processing plants in the U.S. Headquartered in Cincinnati, Ohio, Kroger focuses its charitable efforts on supporting hunger relief, health and wellness initiatives, and local schools and grassroots organizations in the communities it serves. For more information about the Company, please visit www.kroger.com.


'/>"/>
SOURCE The Kroger Co.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
2. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
3. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
4. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
5. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
6. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
7. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
8. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
9. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
10. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
11. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology:
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... from Germany, announced it is bringing its product to the United States as part ... perfected over the last 25 years, Alcovit aims to reduce the productions of nasty ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based ... recently attended the January ECRM Trade Show in Hilton Head, SC, benefiting from ... large range of supplements that keep the body functioning at its peak performance ...
Breaking Medicine News(10 mins):